enVVeno Medical publishes three-year VenoValve data

enVVeno Medical (NVNO) announced that its manuscript titled, “Three-Year Outcomes of Surgical Implantation of a Novel Bioprosthetic Valve for the Treatment of Deep Venous Reflux,” has been published in the in the peer-reviewed journal, Annals of Vascular Surgery. The VenoValve was surgically implanted in the femoral vein of eleven subjects with active or healed venous ulcers. Eight subjects completed three years of follow-up, with key findings including: primary patency of 79% at three years; seven-point improvement Venous Clinical Severity Score and 84% reduction in pain on the Visual Analog Scale. The VenoValve remained safe and effective, achieving target patency and maintaining competence and clinical benefits.